Synopsis: Specialty chemicals manufacturer Dai-ichi Karkaria Ltd (DAICHI) has announced a major ₹10 crore expansion at its Dahej facility to double its Alkoxylation capacity. While the company reported a net loss for FY26, a sequential recovery in Q4 and the decision to self-fund its growth signal a strategic pivot toward a long-term turnaround.
In a strategic move to capitalize on high demand and prepare for the next growth cycle, Dai-ichi Karkaria Limited announced on May 9, 2026, a significant expansion of its Alkoxylation project at the Dahej plant in Gujarat. The company plans to add 5,000 MT per annum of capacity, effectively doubling its current capacity to 10,000 MT per annum.
The rationale for this expansion is rooted in operational necessity; the existing facility is currently running at 95% capacity utilization, leaving virtually no room for organic growth. By doubling its footprint, the company is positioning itself to meet a projected demand recovery in its core sectors, such as Textiles and Paints.
For investors, a key highlight is the financial discipline behind the project: the ₹10 crore investment will be funded entirely through internal accruals. By avoiding new debt, the company is protecting its balance sheet from interest burdens as it navigates a recovery phase.
While FY26 reflected a challenging year for the chemical industry, recent quarterly trends indicate early signs of recovery. After reporting a loss of ₹0.86 crore in Q3 FY26, the company returned to profitability with a net profit of ₹0.09 crore in Q4, supported by an 8.35% sequential increase in revenue.
For the full year FY26, consolidated sales stood at ₹161 crore, down 11.05% from ₹181 crore in FY25 due to softer global chemical prices. The company reported a consolidated net loss of Rs. 0.74 crore for the year but has still recommended a final dividend of 15% (₹1.50 per share), maintaining its commitment to shareholder returns.
At current levels, Dai-ichi Karkaria presents a classic “deep value” turnaround case. The stock is trading at a Price-to-Book (P/B) ratio of 1.04x, a significant discount compared to the historical multiples commanded by Indian specialty chemical players.
The company’s long-term competitive advantage remains its technical collaboration with Dai-ichi Kogyo Seiyaku Co. Ltd (Japan). This partnership ensures that the new capacity at Dahej will produce high-standard alkoxylates that meet international benchmarks, making the company a strong contender for export markets as well as domestic consumption.
Shares of Dai-ichi Karkaria Limited experienced slight selling pressure today as the market processed the mixed earnings report. As of 11:45 AM IST on May 11, 2026, the stock was trading at ₹254.95, down 0.99%.
The stock has faced a challenging year, with a 1-year absolute return of -33%, significantly underperforming the broader Nifty 50 and its chemical sector peers. However, with new capacity scheduled to come online in FY2026-27, the market will be closely watching for the revenue contribution from the Dahej expansion.
Company Overview
Incorporated in 1963, Dai-ichi Karkaria Ltd is a specialist in the development and manufacture of high-performance specialty chemicals for oil fields, construction, and textiles. The company operates as a key player in the Indian chemical landscape, leveraging Japanese technical expertise to provide innovative solutions to industrial clients globally.
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Trade Brains Technologies Private Limited or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor.
